|Articles|September 1, 2003
Kasabach-Merritt Phenomenon
Author(s)Barbara J. Rutledge, Ph.D.
San Francisco - It is important to go back to the literature to study the rare phenomenon known as Kasabach-Merritt phenomenon and review the published reports in light of what we currently know about vascular tumors, according to Beth A. Drolet, M.D. "Most of these lesions do involve the skin, so we as dermatologists can play a big part in diagnosis," said Dr. Drolet, associate professor of dermatology and pediatrics, Medical College of Wisconsin.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
How AI Is Transforming Skin Cancer Diagnosis
2
Oral C5aR Inhibitor INF904 Shows Early Efficacy in HS and CSU Phase 2a Trials
3
Psoriasis Care Evolves as Oral IL-23 Blockers Show Lasting Control
4
Harrison Nguyen, MD, MBA, MPH’s Deep Dive into CSU, Vasculitis, and Autoimmune Blisters
5















